# Ibuprofen 5% Topical Gel CIPT

> **NCT01771822** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 50 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ibuprofen 5% topical gel
- **DRUG:** Topical gel vehicle
- **DRUG:** Sodium lauryl sulfate 0.2%
- **DRUG:** Sodium chloride solution 0.9% (saline)

## Key facts

- **NCT ID:** NCT01771822
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01771822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01771822, "Ibuprofen 5% Topical Gel CIPT". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01771822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*